Advertisement

Topics

Bayer receives FDA approval for myBETAapp and BETACONNECT Navigator

13:22 EDT 20 Jun 2017 | TriMed Media Group

Bayer has received approval for a supplemental Biologics License Application (sBLA) from the U.S. Food and Drug Administration (FDA) in regards to their myBETAapp™ and the BETACONNECT Navigator™. These platforms utilize software to allow patients with multiple sclerosis to auto-administer BETASERON.

Original Article: Bayer receives FDA approval for myBETAapp and BETACONNECT Navigator

NEXT ARTICLE

More From BioPortfolio on "Bayer receives FDA approval for myBETAapp and BETACONNECT Navigator"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...